Scientists have taken a major step toward developing an effective HIV vaccine after a new experimental vaccine successfully ...

A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV ...

A new HIV vaccine has generated powerful broadly neutralizing antibodies in animal studies and has now entered human trials, ...

Researchers have developed a vaccine that has successfully generated "virus-fighting" antibodies in primates, which may help ...

Continuing their journey to develop a vaccine for HIV, Oregon Health & Science University researchers have identified a gene that could have prevented their vaccine from working in humans. Daniel ...

The current presidential administration has ended funding for the Center for HIV/AIDS Vaccine Development (CHAVD), a move that researchers say will likely set efforts to end HIV globally back by a ...

A major challenge in developing a vaccine for HIV is that the virus mutates fast -- very fast. Although a person initially becomes infected with one or a few HIV strains, the virus replicates and ...

After decades of failed HIV vaccines, a new approach that predicts which cells to train, not just what antigen to show, has ...

An experimental HIV vaccine candidate developed by LJI, Scripps Research and IAVI generated high levels of broadly ...

Termination of HIV vaccine studies affects key research institutions, aligning with previous cuts to HIV-related programs under the Trump administration. The administration plans to focus on existing ...

A collaborative research team from LJI, Scripps Research and IAVI has developed an experimental HIV vaccine that successfully ...